-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
CASI Pharmaceuticals, Inc (DE) annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2011 to Q1 2022.
- CASI Pharmaceuticals, Inc (DE) Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2022 was -$2.29M, a 81% increase year-over-year.
- CASI Pharmaceuticals, Inc (DE) annual Net Cash Provided by (Used in) Investing Activities for 2022 was $31.2M.
- CASI Pharmaceuticals, Inc (DE) annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$20.7M, a 0.14% increase from 2020.
- CASI Pharmaceuticals, Inc (DE) annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$20.7M, a 26.2% increase from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)